BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
76 hedge funds and large institutions have $70M invested in BRAINSTORM CELL THERAPUTC in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 8 closing their positions.
Holders
76
Holders Change
+25
Holders Change %
+49.02%
% of All Funds
1.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
21
Reduced
12
Closed
8
Calls
$9.36M
Puts
$38.3M
Net Calls
-$28.9M
Net Calls Change
-$29.2M
Top Buyers
1 |
1
BlackRock
New York
|
$20.8M |
2 |
2
State Street
Boston,
Massachusetts
|
$4.74M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$4.41M |
4 |
AHB
4
Abner Herrman & Brock
Jersey City,
New Jersey
|
$2.68M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$15.2M |